Progentix Orthobiology was established in 2007 and develops CuriOs TM , a unique suite of osteoconductive material products for clinical application in bone regenerative surgery. CuriOs is based on surface- structured ceramic biomaterial scaffolds that, in preclinical testing, have shown excellent bone healing properties.
Progentix Orthobiology concluded an agreement in 2009 with NuVasive, a US-based medical device company. NuVasive collaborates with Progentix to develop synthetic bone substitutes designed to accelerate bone healing. The deal has a total value of over $80 million.